Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,724 public trials 629 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

NCT06248814

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Local Institution - 0004 Prague, PR, Czechia
  • Local Institution - 0009 Pardubice, Czechia
  • Local Institution - 0006 Clermont-Ferrand, France
  • Local Institution - 0010 Nice, France
View all 13 locations
View Trial Details
Completed

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

NCT06723405

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +11 more
Locations
  • Cornerstone Dermatology Coorparoo, Australia
  • Momentum Clinical Research Darlinghurst Darlinghurst, Australia
  • Pacific Clinical Research Network (PCRN) Auckland Auckland, New Zealand
  • Optimal Clinical Trials North Auckland, New Zealand
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

NCT06224348

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States
  • Johnson Dermatology- Site Number : 8401076 Fort Smith, Arkansas, United States
  • Encino Research Center- Site Number : 8401042 Encino, California, United States
  • Marvel Clinical Research- Site Number : 8401102 Huntington Beach, California, United States
View all 167 locations
View Trial Details
Completed

A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)

NCT05526521

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Pediatric Dermatology of Miami Site Number : 8400015 Coral Gables, Florida, United States
  • Treasure Valley Medical Research Site Number : 8400019 Boise, Idaho, United States
  • Washington University School of Medicine- Site Number : 8400004 St Louis, Missouri, United States
  • Boston Childrens Health Physicians Site Number : 8400017 Hawthorne, New York, United States
View all 15 locations
View Trial Details
Completed

Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

NCT03560466

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Arizona Allergy and Immunology Research- Site Number : 8400002 Gilbert, Arizona, United States
  • Asthma and Airway Disease Research Center Site Number : 8400012 Tucson, Arizona, United States
  • Peninsula Research Associates Site Number : 8400001 Rolling Hills Estates, California, United States
  • Division of Pulmonary Medicine and Allergy Medicine- Site Number : 8400006 St Louis, Missouri, United States
View all 81 locations
View Trial Details

Related conditions